Literature DB >> 22377956

The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years.

Shan Zheng1, Jing-Qiao Bai, Jing Li, Jin-Hu Fan, Yi Pang, Qing-Kun Song, Rong Huang, Hong-Jian Yang, Feng Xu, Ning Lu, You-Lin Qiao.   

Abstract

In China, breast cancer is currently the most common malignancy and the sixth leading cause of cancer death in women. But, the characteristics of breast cancer in the whole population are not determined. The aim of this study was to perform a detailed study on pathologic characteristics of breast cancer representing the whole population in China during 1999-2008 and to compare the difference in invasive breast cancer between the Western and Chinese. We randomly collected 4,211 inpatient at seven hospitals in representative geographical regions of China during 1999-2008. All the hospitals had the ability of comprehensive cancer treatment. The pathologic characters including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status were surveyed. The shift of pathologic characters was evaluated and the data from China were also compared with those of the Western, both using Chi-square test. We found as follow. (i) The median age of the patients was 48 years and showed the similar characters of Asia. (ii) Breast cancer in China showed more invasive ductal carcinoma with larger tumor size, later stage, lower ER and PR expression and higher HER2 overexpression than those in the Western (p < 0.001). (iii) Both tumor size and stage at diagnosis decreased year by year (p < 0.001). Breast cancer in China showed more aggressive behavior than those in western countries, although tumor size and stage at diagnosis decreased by year during 1999-2008. We addressed the urgent needs for employ race-specific breast cancer screen, diagnosis methods, and therapeutic models in China.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377956     DOI: 10.1002/ijc.27513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China.

Authors:  Rui-Jue Wang; Lin-Jie Lu; Liang-Bin Jin; Hong-Yuan Li; Guo-Sheng Ren; Kai-Nan Wu; Sheng-Chun Liu; Ling-Quan Kong
Journal:  Med Oncol       Date:  2013-12-12       Impact factor: 3.064

2.  Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.

Authors:  Qing-Kun Song; Xiao-Li Wang; Xin-Na Zhou; Hua-Bing Yang; Yu-Chen Li; Jiang-Ping Wu; Jun Ren; Herbert Kim Lyerly
Journal:  Oncologist       Date:  2015-05-22

3.  Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer.

Authors:  Shunrong Li; Jieqiong Liu; Yaping Yang; Yunjie Zeng; Heran Deng; Haixia Jia; Qian Li; Huiyi Feng; Yangyang Li; Erwei Song; Qiang Liu; Fengxi Su
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-09       Impact factor: 4.553

4.  Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.

Authors:  Hongyi Wei; Minghao Wang; Jianghua Ou; Weihua Jiang; Fuguo Tian; Yuan Sheng; Hengyu Li; Hong Xu; Ruishan Zhang; Aihua Guan; Changqing Wang; Hongchuan Jiang; Yu Ren; Jianjun He; Jian Liu; Weiwei Huang; Ning Liao; Xiangjun Cai; Jia Ming; Rui Ling; Yan Xu; Chunyan Hu; Jianguo Zhang; Baoliang Guo; Lizhi Ouyang; Ping Shuai; Zhenzhen Liu; Ling Zhong; Ruilin Jing; Zhen Zeng; Meng Zhang; Ting Zhang; Zhaoling Xuan; Xuanni Tan; Junbin Liang; Qinwen Pan; Li Chen; Fan Zhang; Linjun Fan; Yi Zhang; Xinhua Yang; Jingbo Li; Chongjian Chen; Jun Jiang
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

5.  YAP1/MMP7/CXCL16 axis affects efficacy of neoadjuvant chemotherapy via tumor environment immunosuppression in triple-negative breast cancer.

Authors:  Jia-Qi Yuan; Ke-Jing Zhang; Shou-Man Wang; Lei Guo
Journal:  Gland Surg       Date:  2021-09

6.  Distinct breast cancer subtypes in women with early-onset disease across races.

Authors:  Mandeep Singh; Yi Ding; Li-Ying Zhang; Dong Song; Yun Gong; Sylvia Adams; Dara S Ross; Jin-Hua Wang; Shruti Grover; Dinesh Chandra Doval; Charles Shao; Zi-Li He; Victor Chang; Warren W Chin; Fang-Ming Deng; Baljit Singh; David Zhang; Ru-Liang Xu; Peng Lee
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

7.  Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment.

Authors:  Guang-yan Ji; Liang-bin Jin; Rui-jue Wang; Yang Bai; Zi-xiang Yao; Lin-jie Lu; Jian-bo Huang; Sheng-chun Liu; Hong-yuan Li; Zi-wei Wang; Guo-sheng Ren; Kai-nan Wu; Ling-quan Kong
Journal:  Med Oncol       Date:  2013-08-08       Impact factor: 3.064

8.  Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.

Authors:  Guochun Zhang; Yulei Wang; Bo Chen; Liping Guo; Li Cao; Chongyang Ren; Lingzhu Wen; Kai Li; Minghan Jia; Cheukfai Li; Hsiaopei Mok; Xiaoqing Chen; Guangnan Wei; Jiali Lin; Zhou Zhang; Ting Hou; Han Han-Zhang; Chenglin Liu; Hao Liu; Jing Liu; Charles M Balch; Funda Meric-Bernstam; Ning Liao
Journal:  Ann Transl Med       Date:  2019-04

9.  HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients.

Authors:  Tao Qin; Zhongyu Yuan; Roujun Peng; Bing Bai; Yanxia Shi; Xiaoyu Teng; Donggeng Liu; Shusen Wang
Journal:  Onco Targets Ther       Date:  2013-04-09       Impact factor: 4.147

10.  Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line.

Authors:  Ling Wang; Fubiao Kang; Jie Li; Jing Zhang; Baoen Shan
Journal:  Cancer Cell Int       Date:  2013-02-12       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.